GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Scienture Holdings Inc (NAS:SCNX) » Definitions » Return-on-Tangible-Asset

SCNX (Scienture Holdings) Return-on-Tangible-Asset : -156.46% (As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Scienture Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Scienture Holdings's annualized Net Income for the quarter that ended in Mar. 2025 was $-12.26 Mil. Scienture Holdings's average total tangible assets for the quarter that ended in Mar. 2025 was $7.83 Mil. Therefore, Scienture Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was -156.46%.

The historical rank and industry rank for Scienture Holdings's Return-on-Tangible-Asset or its related term are showing as below:

SCNX' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -233.4   Med: -51.49   Max: 92.44
Current: -133.11

During the past 13 years, Scienture Holdings's highest Return-on-Tangible-Asset was 92.44%. The lowest was -233.40%. And the median was -51.49%.

SCNX's Return-on-Tangible-Asset is ranked worse than
91.57% of 688 companies
in the Healthcare Providers & Services industry
Industry Median: 1.55 vs SCNX: -133.11

Scienture Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for Scienture Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scienture Holdings Return-on-Tangible-Asset Chart

Scienture Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.65 -68.33 -73.28 -219.71 92.44

Scienture Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 580.65 -46.45 -102.46 -335.27 -156.46

Competitive Comparison of Scienture Holdings's Return-on-Tangible-Asset

For the Pharmaceutical Retailers subindustry, Scienture Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings's Return-on-Tangible-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's Return-on-Tangible-Asset falls into.


;
;

Scienture Holdings Return-on-Tangible-Asset Calculation

Scienture Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=9.066/( (12.533+7.081)/ 2 )
=9.066/9.807
=92.44 %

Scienture Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=-12.256/( (7.081+8.586)/ 2 )
=-12.256/7.8335
=-156.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Scienture Holdings  (NAS:SCNX) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Scienture Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Scienture Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Scienture Holdings Business Description

Traded in Other Exchanges
N/A
Address
6308 Benjamin Road, Suite 708, Tampa, FL, USA, 33634
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Executives
A. Jeffrey Newell director 645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell director 17537 DARBY LANE, LUTZ FL 33558
Janet Huffman officer: CFO, PAO, PFO 5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson director 17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings director 3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel director, 10 percent owner, officer: President 17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts director PO BOX 15012, SARASOTA FL 34277
Gary Augusta director 700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss officer: CFO 17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu director, 10 percent owner, officer: CEO 8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida director 1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope director 4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu 10 percent owner 17537 DARBY LANE, LUTZ FL 33558

Scienture Holdings Headlines

From GuruFocus

Q4 2021 TRxADE Health Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024